Expense Ratio Rating
4 /10
Expense Rating
5 /10
Market Score
1 /10
Category Score
5 /10
Market Size
1 /10
We found 9,682 Allocation Target-Date funds. Here they are ordered by FI Score.
Hartford Schroders Emerging Markets Multi-Sector Bond Fund Class A
Expenses: 1.11% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
Goldman Sachs Local Emerging Markets Debt Fund Class A
Expenses: 1.23% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
Wells Fargo Real Return Fund - Class C
Expenses: 1.52% (Better than 0% of similar funds)
This is a bad choice for a Government Bond Bond fund. See why »
Needham Growth Fund Retail Class
Expenses: 1.98% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »
MFS Blended Research Emerging Markets Equity Fund Class C
Expenses: 1.99% (Better than 0% of similar funds)
This is a bad choice for a Emerging Markets International Stocks fund. See why »
Hanlon Managed Income Fund Class I
Expenses: 1.43% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
Alger Responsible Investing Fund Class C
Expenses: 2.16% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
Dunham Small Cap Growth Fund Class N
Expenses: 1.88% (Better than 0% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why »
Rydex S&P MidCap 400 Pure Growth Fund Class A
Expenses: 1.62% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »
Meridian Enhanced Equity Fund® A Class
Expenses: 2.00% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
Gabelli Focus Five Fund Class A
Expenses: 1.64% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Blend US Stocks fund. See why »
DWS Health and Wellness Fund - Class C
Expenses: 2.09% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
MFS Blended Research Emerging Markets Equity Fund Class B
Expenses: 1.99% (Better than 0% of similar funds)
This is a bad choice for a Emerging Markets International Stocks fund. See why »
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map